Nucleophosmin mutation in de-novo acute myeloid leukemia.

about

Nucleophosmin mutation in de-novo acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q50951275

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Nucleophosmin mutation in de-novo acute myeloid leukemia.

@en

Nucleophosmin mutation in de-novo acute myeloid leukemia.

@nl

type

Item

label

Nucleophosmin mutation in de-novo acute myeloid leukemia.

@en

Nucleophosmin mutation in de-novo acute myeloid leukemia.

@nl

prefLabel

Nucleophosmin mutation in de-novo acute myeloid leukemia.

@en

Nucleophosmin mutation in de-novo acute myeloid leukemia.

@nl

P1476

Nucleophosmin mutation in de-novo acute myeloid leukemia

@en

P2093

Neelam Varma

http://www.w3.org/2001/XMLSchema#string

Shano Naseem

http://www.w3.org/2001/XMLSchema#string

Subhash Varma

http://www.w3.org/2001/XMLSchema#string

P2860

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation.

The incidence and clinical significance of nucleophosmin mutations in childhood AML.

Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.

P304

77-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12442

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pulkit Rastogi

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26669619

http://www.w3.org/2001/XMLSchema#string